Submitted by Anonymous (not verified) on 18 September 2023 - 16:46
Human medicines European public assessment report (EPAR): Apealea, paclitaxel, Ovarian Neoplasms, Date of authorisation: 20/11/2018, Revision: 7, Status: Authorised
Source: